CE Serum Plasma Glycosylated Hemoglobin Test Kit Cystatin C Rapid Test

Cystatin C detection reagent (immunofluorescence chromatography) (CysC)

CysC overview

Cysteinase proteinase inhibitor (CPI) is named cystatin C. Cystatin C in circulation is removed only through glomerular filtration, which is an endogenous marker reflecting the change of glomerular filtration rate, and reabsorbed in the proximal convoluted tubules, but is metabolized and decomposed completely after reabsorption, and does not return to blood. Therefore, the concentration of cystatin C in the blood is determined by glomerular filtration rate, and does not depend on any external factors, such as gender, age and diet, It is an ideal endogenous marker reflecting the change of glomerular filtration rate.

CysC performance index

Clinical significance of CysC

• The most ideal endogenous marker for GFR reaction
• Early diagnosis and monitoring of renal diseases
• Renal function assessment of AKI high risk population
• The detection of renal function in the process of chronic disease management

Sensitivity comparison of cystatin C and serum creatinine in the evaluation of GFR

Application Department

Internal medicine, pediatrics, orthopedics, cardiology, gynecology, obstetrics and Gynecology, emergency, ICU, Nephrology, oncology, surgery, etc

Clinical comparison of CysC

Company profile

Zhongxiu Science And Technology Co.,Ltd., is a high-tech enterprise engaged in the research and development, production and operation of in vitro diagnostic products. The in vitro diagnostic products developed by the company cover POCT series, microbial series, biochemical series and immune series reagents and supporting instruments.
The company has always adhered to the core concept of "fast and accurate, living up to life", committed to providing society with excellent products and services, and contributing to the cause of human health.

Zhongxiu Science And Technology Co.,Ltd., founded in 2016, is located in Dingluan Industrial Zone, Changyuan City, Henan Province. The company covers an area of about 100 acres and the initial investment is about 200 million yuan. The company has a scientific and complete management system, a purification workshop of national standards, and a fully functional inspection center. On this basis, the company will continue to invest in research and development, accumulate technical strength, update manufacturing equipment, improve production technology, improve inspection technology, improve product quality, and provide customers with safe and effective in vitro diagnostic products.

Zhongxiu Science And Technology Co., Ltd. is a high-tech enterprise engaged in the research and development, production and operation of in vitro diagnostic products. The in vitro diagnostic products developed by the company cover POCT series, immune series, microbial series and other reagents and supporting instruments.

The company has always adhered to the core concept of “fast and accurate, living up to life”, committed to providing society with excellent products and services, and contributing to the cause of human health.